![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
News
By Winter 2023 Moderna eyes Combined COVID 19 And Flu Shot
According to Moderna’s CEO, Stephane Bancel, the company is aiming to bring to the market a combination of COVID-19 and influenza booster in the...
Clinical Trials
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
Pfizer Inc. and BioNTech SE announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine candidate...
Press Releases
Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19
Gilead Sciences, Inc. announced that the U.S. FDA has granted expedited approval of a supplemental new drug application (sNDA) for Veklury® (remdesivir) for the...
News
Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Australia's Therapeutic Goods Administration (TGA) has...
News
FDA may permit Pfizer COVID vaccine for kids up to 5 years
Dr Anthony Fauci, the chief medical advisor to the White House has gone on to confirm that FDA might as well approve the Pfizer...
Clinical Trials
Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant
Pfizer Inc. shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir...
News
Stempeutics gets DCGI nod for Phase 3 clinical trial on its product for treating COVID patients
Stempeutics, a group company of Manipal Education and Medical Group (MEMG) said it has received DCGI clearance to conduct Phase 3 clinical trial on...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read